Loading...
Loading...
Browse all stories on DeepNewz
VisitWhere will the first commercial application of DBS for spinal cord injury occur by end of 2025?
Switzerland • 25%
United States • 25%
European Union • 25%
Other • 25%
Announcements from medical device companies or healthcare providers
Swiss Researchers Restore Walking in Paraplegic Patients with Brain Stimulation Targeting Lateral Hypothalamus
Dec 2, 2024, 05:15 PM
Swiss researchers have achieved a groundbreaking medical advancement by enabling two paraplegic patients with partial spinal cord injuries to walk again using deep brain stimulation (DBS). The technique involves implanting electrodes in the lateral hypothalamus, a brain region not traditionally associated with movement, to stimulate neural activity. This innovative approach has shown promising results, allowing the patients to walk short distances, climb stairs, and improve lower limb movements. The study, published in Nature Medicine, also demonstrated similar recovery outcomes in preclinical models, including mice and rats. These findings highlight the potential of DBS as a transformative therapy for spinal cord injury rehabilitation.
View original story
Mayo Clinic • 25%
Johns Hopkins Hospital • 25%
Cleveland Clinic • 25%
Other • 25%
United States • 25%
European Union • 25%
China • 25%
Other • 25%
Full mobility restoration in a patient • 25%
Widespread clinical trials • 25%
FDA approval • 25%
None of the above • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
United States • 25%
European Union • 25%
China • 25%
Other • 25%
Switzerland • 25%
Germany • 25%
France • 25%
Other • 25%
By UCL Hospital • 25%
By a US-based hospital • 25%
By a European hospital (excluding UCL) • 25%
By an Asian hospital • 25%
USA • 25%
EU • 25%
Japan • 25%
Other • 25%
Government grants • 25%
Private investors • 25%
Pharmaceutical companies • 25%
Non-profit organizations • 25%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
1-2 countries • 25%
More than 10 countries • 25%
6-10 countries • 25%
3-5 countries • 25%